These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24842699)

  • 1. Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data.
    Mancia G; Zambon A; Soranna D; Merlino L; Corrao G
    J Hypertens; 2014 Aug; 32(8):1708-15; discussion 1716. PubMed ID: 24842699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments.
    Corrao G; Zambon A; Parodi A; Merlino L; Mancia G
    Am J Hypertens; 2012 May; 25(5):549-55. PubMed ID: 22278212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.
    Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G
    J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women discontinue antihypertensive drug therapy more than men. Evidence from an Italian population-based study.
    Rea F; Mella M; Monzio Compagnoni M; Cantarutti A; Merlino L; Mancia G; Corrao G
    J Hypertens; 2020 Jan; 38(1):142-149. PubMed ID: 31464801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study.
    Wong MC; Lau RK; Jiang JY; Griffiths SM
    J Clin Pharm Ther; 2012 Jun; 37(3):335-41. PubMed ID: 22023456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antihypertensive drugs in three European countries.
    Nicotra F; Wettermark B; Sturkenboom MC; Parodi A; Bellocco R; Ekbom A; Merlino L; Leimanis A; Mancia G; Fored M; Corrao G
    J Hypertens; 2009 Sep; 27(9):1917-22. PubMed ID: 19506527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.
    Signorovitch JE; Samuelson TM; Ramakrishnan K; Marynchenko M; Wu EQ; Blum SI; Ramasamy A; Chen S
    Curr Med Res Opin; 2012 Apr; 28(4):591-9. PubMed ID: 22352883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
    Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S
    Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cardiovascular profile on persistence associated with antihypertensive medications.
    Midy F; Rudnichi A
    Int J Clin Pract; 2013 Dec; 67(12):1334-41. PubMed ID: 24246212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies.
    Elliott WJ; Plauschinat CA; Skrepnek GH; Gause D
    J Am Board Fam Med; 2007; 20(1):72-80. PubMed ID: 17204738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients.
    Shin S; Song H; Oh SK; Choi KE; Kim H; Jang S
    Hypertens Res; 2013 Nov; 36(11):1000-5. PubMed ID: 23966057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing antihypertensive medication compliance in Taiwan: a nationwide population-based study.
    Lee CY; Huang CC; Shih HC; Huang KH
    Eur J Prev Cardiol; 2013 Dec; 20(6):930-7. PubMed ID: 22689418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
    Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
    Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
    BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions.
    Wong MC; Jiang JY; Lam AT; Fung H; Griffiths S; Mercer SW
    J Hum Hypertens; 2008 Oct; 22(10):714-6. PubMed ID: 18650836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
    Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
    Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.